Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The rising initiatives to reduce the number of fatalities caused by cancer are aiding the industry growth. The increasing research and development (R&D) due to the rising investments by the government and various other organisations to promote awareness about cancer while developing advanced and efficient treatments. For instance, Centres for Disease Control and Prevention (CDC) invested USD 145 million in cancer screening while initiating a campaign called “Screen for Life”; such developments positively impact the cancer screening industry. In addition, the rising demand for effective screening without dangerous side effects can propel the market growth in the forecast period. Furthermore, the rising awareness about the benefits of early detection in both developed and emerging countries are significantly contributing to the cancer screening industry.
Epigenomics AG (FRA: ECX), one of the leading players in the market, unveiled its next-generation liquid biopsy test for colorectal cancer screening in January 2021. The screening is built on the company’s expertise in liquid biopsy and DNA methylation biomarkers. Moreover, the algorithm for the screening was trained in a study with 454 samples comprising CRC patients and clinical controls. Additionally, this nest generation multi-target real-time PCR blood test is based on a new proprietary core DNA methylation technology that provides valid results for greater than 99% of samples analysed and a fast, easy to use and affordable option for detecting CRC in a liquid biopsy. The development of such products is anticipated to provide impetus to the market growth in the forecast period.
Market Analysis by Cancer Type, Technique, Stage, Gender, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global market for cancer screening are DiaSorin S.p.A., Epigenomics AG, Techlab, Inc., Positive Biosciences Limited, MedGenome Labs Ltd, and 20/20 GeneSystems, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.